A lab technician extracts a portion of a COVID-19 vaccine candidate during testing at the Chula Vaccine Research Center, run by Chulalongkorn University in Bangkok, Thailand, Monday, May 25, 2020. Researchers in Thailand claim to have promising results with the vaccination on mice, and have begun testing on monkeys. (AP Photo/Sakchai Lalit) Vaccines will be manufactured in a handful of locations and then go through a sprawling infrastructure of transportation and warehouses to get to their final destinations, according to JLL. Complicating that journey will be the different temperature and freezer requirements of the three leading vaccines. (Photo: AP Photo/Sakchai Lalit)

The cold storage asset class has been seeing high levels of investment, but this may not necessarily translate into a smooth supply chain for the distribution of COVID-19 vaccines. The answer, experts say, may be a mix of strategies for distributing the vaccine.

Want to continue reading?
Become a Free PropertyCasualty360 Digital Reader

Your access to unlimited PropertyCasualty360 content isn’t changing.
Once you are an ALM digital member, you’ll receive:

  • Breaking insurance news and analysis, on-site and via our newsletters and custom alerts
  • Weekly Insurance Speak podcast featuring exclusive interviews with industry leaders
  • Educational webcasts, white papers, and ebooks from industry thought leaders
  • Critical converage of the employee benefits and financial advisory markets on our other ALM sites, BenefitsPRO and ThinkAdvisor
NOT FOR REPRINT

© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.

Leslie Shaver

Les Shaver has been covering commercial and residential real estate for almost 20 years. His work has appeared in Multifamily Executive, Builder, units, Arlington Magazine in addition to GlobeSt.com and Real Estate Forum.

Commercial Lines
Public Sector Risk